# Bristol-Myers Squibb Company (BMY) — Q3-2018 Earnings Results

**Report date:** 2018-10-25 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q3-2018

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 0.78%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.09 | N/A | +14.96% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting the strength of their product pipeline. They emphasized their commitment to driving future growth.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value through our innovative pipeline.

### Guidance Changes

No guidance updates were provided during the call.

### What It Means

Bristol Myers Squibb's earnings report shows a strong performance in EPS, exceeding expectations. The stock reacted positively, increasing by 0.78%. This suggests investor confidence in the company's current trajectory, although no guidance was offered for future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q3-2018_